Related Experiment Videos
Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists
1Department of Internal Medicine, Medical College of Virginia, Richmond.
Insights
Different calcium antagonists have unique effects on heart function and blood vessels. Understanding these differences is crucial for selecting the right medication for patients with cardiovascular conditions like heart failure or hypertension.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Calcium antagonists exhibit diverse in vitro and in vivo effects on cardiovascular function.
- These effects stem from differential responses in cardiac and vascular smooth muscle to calcium channel blockade.
Purpose of the Study:
- To highlight the clinical implications of varying calcium antagonist properties.
- To guide the selection of appropriate calcium antagonists based on specific patient conditions.
Main Methods:
- Review of electrophysiologic, hemodynamic, and contractile effects of available calcium antagonists.
- Analysis of differential cardiac and vascular smooth muscle responses to calcium channel blockade.
Main Results:
- Calcium antagonists differ significantly in their impact on cardiovascular function.
- Dihydropyridine agents (e.g., nifedipine, amlodipine) primarily cause peripheral vasodilation, reducing afterload.
- Verapamil is effective in hypertrophic cardiomyopathy with arrhythmias; diltiazem may pose risks in post-MI patients with congestion.
- Most current calcium antagonists may adversely affect left ventricular function, especially in heart failure.
Conclusions:
- Recognizing and utilizing the distinct properties of calcium antagonists is essential for optimal clinical outcomes.
- Careful patient selection is required to maximize benefits and minimize risks associated with different calcium antagonists.
- Newer agents like amlodipine require further investigation for safety in congestive heart failure.
Abstract:
The calcium antagonists currently available exert significantly different in vitro and in vivo electrophysiologic, hemodynamic, and contractile effects on cardiovascular function, mediated through differential cardiac and vascular smooth muscle responses to calcium channel blockade. These differences have important implications regarding choice of agent in specific clinical conditions, such as sinus or atrioventricular nodal disease, depressed left ventricular function, or congestive heart failure--conditions that may coexist with angina or hypertension. Recognizing and utilizing the properties of the different calcium antagonists is important to ensure maximally effective clinical outcomes. For example, in patients with hypertrophic cardiomyopathy and supraventricular arrhythmias, verapamil is singularly effective, whereas in post-myocardial infarction patients with pulmonary congestion, diltiazem may produce an added risk. Calcium antagonists of the dihydropyridine class, such as nifedipine and amlodipine, have the greatest peripheral vasoselective effects and thus the greatest potential to reduce afterload, minimizing direct left ventricular depression of contractility. Despite favorable effects of calcium antagonists, most of the agents currently available are not clearly safe in congestive heart failure and may adversely affect left ventricular function. However, newer calcium antagonists such as amlodipine are being investigated with regard to their safety in congestive heart failure.